EARLY IMPACT OF TREATMENT WITH RIBAROXABAN ON THROMBOSIS REGRESSION ASSESSED BY QUANTITATIVE AND VOLUME MEASUREMENTS AMONG PATIENTS WITH ACUTE VENOUS THROMBUS: PROSPECTIVE MULTICENTER STUDY